BioStock: Saniona´s CEO comments on the collaboration with AstronauTx

Saniona has entered into a new research collaboration with AstronauTx in Alzheimer’s disease and other neurodegenerative conditions. Saniona may receive up to SEK 1.9 billion or $177 million in milestone payments, as well as royalties on worldwide net sales of resulting products under the collaboration. BioStock talked to Saniona´s CEO Thomas Feldthus to learn more.

Read the full interview with Saniona´s CEO Thomas Feldthus at biostock.se:

https://www.biostock.se/en/2023/07/sanionas-ceo-comments-on-the-collaboration-with-astronautx/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/